Mouse CD146/MCAM is a marker of natural killer cell maturation

被引:41
作者
Despoix, Nicolas [1 ]
Walzer, Thierry [2 ]
Jouve, Nathalie [1 ]
Blot-Chabaud, Marcel [1 ]
Bardin, Nathalie [1 ]
Paul, Pascale [1 ,3 ]
Lyonnet, Luc [3 ]
Vivier, Eric [2 ]
Dignat-George, Francoise [1 ]
Vely, Frederic [1 ]
机构
[1] Univ Mediterranee, Fac Pharm, INSERM, UMR S608, F-13385 Marseille 5, France
[2] Univ Mediterranee, CNRS, UMR 6102, INSERM,U631,CIML, F-13385 Marseille 5, France
[3] Hop Conception, Hematol Unit, Lab Hematol Cellulaire Specialisee, Marseille, France
关键词
Adhesion; Antibodies; CD146/MCAM; Maturation; NK cells;
D O I
10.1002/eji.200838469
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD146/melanoma cell adhesion molecule is an adhesion molecule expressed by endothelial cells and by a small fraction of activated T and B lymphocytes in humans. In order to analyze the pattern of CD146 expression in mouse leukocytes at steady-state conditions, we generated a set of novel rat anti-mouse CD146 monoclonal antibodies. CD146 expression was undetectable on monocytes, dendritic cells, T cells or B cells, but was expressed on about 30% of neutrophils and 60% of NK cells. Within murine lymphocytes, CD146 was defined as a novel NK-specific surface molecule. An increased percentage of CD146(+) cells was found in the most mature CD27(-)CD11b(+) NK cell subpopulation, which also displays higher expression of Ly49C/I, Ly49D and KLRG1 and lower expression of NKG2A/C/E molecules. CD146(+) NK cells were found to be less cytotoxic and produce less IFN-gamma than CD146(-) NK cells upon stimulation with target cells or activating antibodies. These findings define CD146 as a marker of mouse NK cell maturation that may be used as an alternative to the combined use of CD27 and CD11b staining to detect final stages of NK cell maturation.
引用
收藏
页码:2855 / 2864
页数:10
相关论文
共 35 条
[1]  
Alais S, 2001, J CELL SCI, V114, P1847
[2]   Activation of human endothelial cells via S-endo-1 antigen (CD146) stimulates the tyrosine phosphorylation of focal adhesion kinase p125FAK [J].
Anfosso, F ;
Bardin, N ;
Francès, V ;
Vivier, E ;
Camoin-Jau, L ;
Sampol, J ;
Dignat-George, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (41) :26852-26856
[3]   Outside-in signaling pathway linked to CD146 engagement in human endothelial cells [J].
Anfosso, F ;
Bardin, N ;
Vivier, E ;
Sabatier, F ;
Sampol, J ;
Dignat-George, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (02) :1564-1569
[4]   Identification of the S-Endo 1 endothelial-associated antigen [J].
Bardin, N ;
Frances, V ;
Lesaule, G ;
Horschowski, N ;
George, F ;
Sampol, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 218 (01) :210-216
[5]   Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion [J].
Bardin, N ;
Anfosso, F ;
Massé, JM ;
Cramer, E ;
Sabatier, F ;
Le Bivic, A ;
Sampol, J ;
Dignat-George, F .
BLOOD, 2001, 98 (13) :3677-3684
[6]   CLONING, MAPPING, AND CHARACTERIZATION OF ACTIVATED LEUKOCYTE-CELL ADHESION MOLECULE (ALCAM), A CD6 LIGAND [J].
BOWEN, MA ;
PATEL, DD ;
LI, X ;
MODRELL, B ;
MALACKO, AR ;
WANG, WC ;
MARQUARDT, H ;
NEUBAUER, M ;
PESANDO, JM ;
FRANCKE, U ;
HAYNES, BF ;
ARUFFO, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (06) :2213-2220
[7]  
CAMPBELL IG, 1994, CANCER RES, V54, P5761
[8]   Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system [J].
Cayrol, Romain ;
Wosik, Karolina ;
Berard, Jennifer L. ;
Dodelet-Devillers, Aurore ;
Ifergan, Igal ;
Kebir, Hania ;
Haqqani, Arsalan S. ;
Kreymborg, Katharina ;
Krug, Sebastian ;
Moumdjian, Robert ;
Bouthillier, Alain ;
Becher, Burkhard ;
Arbour, Nathalie ;
David, Samuel ;
Stanimirovic, Danica ;
Prat, Alexandre .
NATURE IMMUNOLOGY, 2008, 9 (02) :137-145
[9]   Critical roles of CD146 in zebrafish vascular development [J].
Chan, B ;
Sinha, S ;
Cho, D ;
Ramchandran, R ;
Sukhatme, VP .
DEVELOPMENTAL DYNAMICS, 2005, 232 (01) :232-244
[10]   The biology of human natural killer-cell subsets [J].
Cooper, MA ;
Fehniger, TA ;
Caligiuri, MA .
TRENDS IN IMMUNOLOGY, 2001, 22 (11) :633-640